October 2, 2022

The Japan Herald

About Japan, Global Green Energy and Space Market

Biologics Contract Manufacturinge Market Trends and Forecast Report 2022 | By Players, Types, Applications and Regions

7 min read

The QY Research released a latest market research report on the global and United States Biologics Contract Manufacturinge market, which is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Biologics Contract Manufacturinge will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

 

For United States market, this report focuses on the Biologics Contract Manufacturinge size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

 

For More Information About This Report, Please Enter:

https://us.qyresearch.com/reports/353444/biologics-contract-manufacturing

 

Segment by Type

MABs

Recombinant Protein

Others

 

Segment by Application

Oncology

Immunological Disorders

Cardiovascular Disorders (CVDs)

Hematological Disorders

Others

 

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

 

By Company

Wuxi Biologics

Abzena Ltd.

FUJIFILM Diosynth Biotechnologies U.S.A., Inc.

Boehringer Ingelheim GmbH

Lonza

SamsungBiologics

Abbvie

Catalent

Bioreliance

Thermo Fischer (Patheon)

Eurofins CDMO

 

 

 

The Goal of the Report

To study and analyze the global Biologics Contract Manufacturinge  consumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.

To understand the structure of Biologics Contract Manufacturinge  by identifying its various sub segments.

Focuses on the key global Biologics Contract Manufacturinge  manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Biologics Contract Manufacturinge  with respect to individual growth trends, prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).

To project the consumption of Biologics Contract Manufacturinge  sub markets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

 

Target Audience

> Biologics Contract Manufacturinge  companies

> Research organizations

> Government Organizations

> Research/Consultancy firms

 

Table of Contents

1 Study Coverage
1.1 Biologics Contract Manufacturing Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million) Introduction
1.2 Global Biologics Contract Manufacturing Outlook 2017 VS 2022 VS 2028
1.2.1 Global Biologics Contract Manufacturing Market Size for the Year 2017-2028
1.2.2 Global Biologics Contract Manufacturing Market Size for the Year 2017-2028
1.3 Biologics Contract Manufacturing Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Biologics Contract Manufacturing in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Biologics Contract Manufacturing Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Biologics Contract Manufacturing Market Dynamics
1.4.1 Biologics Contract Manufacturing Industry Trends
1.4.2 Biologics Contract Manufacturing Market Drivers
1.4.3 Biologics Contract Manufacturing Market Challenges
1.4.4 Biologics Contract Manufacturing Market Restraints
1.5 Study Objectives
1.6 Years Considered

2 Biologics Contract Manufacturing by Type
2.1 Biologics Contract Manufacturing Market Segment by Type
2.1.1 MABs
2.1.2 Recombinant Protein
2.1.3 Others
2.2 Global Biologics Contract Manufacturing Market Size by Type (2017, 2022 & 2028)
2.3 Global Biologics Contract Manufacturing Market Size by Type (2017-2028)
2.4 United States Biologics Contract Manufacturing Market Size by Type (2017, 2022 & 2028)
2.5 United States Biologics Contract Manufacturing Market Size by Type (2017-2028)

3 Biologics Contract Manufacturing by Application
3.1 Biologics Contract Manufacturing Market Segment by Application
3.1.1 Oncology
3.1.2 Immunological Disorders
3.1.3 Cardiovascular Disorders (CVDs)
3.1.4 Hematological Disorders
3.1.5 Others
3.2 Global Biologics Contract Manufacturing Market Size by Application (2017, 2022 & 2028)
3.3 Global Biologics Contract Manufacturing Market Size by Application (2017-2028)
3.4 United States Biologics Contract Manufacturing Market Size by Application (2017, 2022 & 2028)
3.5 United States Biologics Contract Manufacturing Market Size by Application (2017-2028)

4 Global Biologics Contract Manufacturing Competitor Landscape by Company
4.1 Global Biologics Contract Manufacturing Market Size by Company
4.1.1 Top Global Biologics Contract Manufacturing Companies Ranked by Revenue (2021)
4.1.2 Global Biologics Contract Manufacturing Revenue by Player (2017-2022)
4.2 Global Biologics Contract Manufacturing Concentration Ratio (CR)
4.2.1 Biologics Contract Manufacturing Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Biologics Contract Manufacturing in 2021
4.2.3 Global Biologics Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Biologics Contract Manufacturing Headquarters, Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million) Type
4.3.1 Global Biologics Contract Manufacturing Headquarters and Area Served
4.3.2 Global Biologics Contract Manufacturing Companies Revenue in Biologics Contract Manufacturing Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Biologics Contract Manufacturing Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Biologics Contract Manufacturing Market Size by Company
4.5.1 Top Biologics Contract Manufacturing Players in United States, Ranked by Revenue (2021)
4.5.2 United States Biologics Contract Manufacturing Revenue by Players (2020, 2021 & 2022)

5 Global Biologics Contract Manufacturing Market Size by Region
5.1 Global Biologics Contract Manufacturing Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Biologics Contract Manufacturing Market Size by Region (2017-2028)
5.2.1 Global Biologics Contract Manufacturing Market Size by Region: 2017-2022
5.2.2 Global Biologics Contract Manufacturing Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Biologics Contract Manufacturing Market Size YoY Growth 2017-2028
6.1.2 North America Biologics Contract Manufacturing Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Biologics Contract Manufacturing Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Biologics Contract Manufacturing Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Biologics Contract Manufacturing Market Size YoY Growth 2017-2028
6.3.2 Europe Biologics Contract Manufacturing Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Biologics Contract Manufacturing Market Size YoY Growth 2017-2028
6.4.2 Latin America Biologics Contract Manufacturing Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa Biologics Contract Manufacturing Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Biologics Contract Manufacturing Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE

7 Company Profiles
7.1 Wuxi Biologics
7.1.1 Wuxi Biologics Company Details
7.1.2 Wuxi Biologics Business Overview
7.1.3 Wuxi Biologics Biologics Contract Manufacturing Introduction
7.1.4 Wuxi Biologics Revenue in Biologics Contract Manufacturing Business (2017-2022)
7.1.5 Wuxi Biologics Recent Development
7.2 Abzena Ltd.
7.2.1 Abzena Ltd. Company Details
7.2.2 Abzena Ltd. Business Overview
7.2.3 Abzena Ltd. Biologics Contract Manufacturing Introduction
7.2.4 Abzena Ltd. Revenue in Biologics Contract Manufacturing Business (2017-2022)
7.2.5 Abzena Ltd. Recent Development
7.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
7.3.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
7.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
7.3.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Introduction
7.3.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biologics Contract Manufacturing Business (2017-2022)
7.3.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Development
7.4 Boehringer Ingelheim GmbH
7.4.1 Boehringer Ingelheim GmbH Company Details
7.4.2 Boehringer Ingelheim GmbH Business Overview
7.4.3 Boehringer Ingelheim GmbH Biologics Contract Manufacturing Introduction
7.4.4 Boehringer Ingelheim GmbH Revenue in Biologics Contract Manufacturing Business (2017-2022)
7.4.5 Boehringer Ingelheim GmbH Recent Development
7.5 Lonza
7.5.1 Lonza Company Details
7.5.2 Lonza Business Overview
7.5.3 Lonza Biologics Contract Manufacturing Introduction
7.5.4 Lonza Revenue in Biologics Contract Manufacturing Business (2017-2022)
7.5.5 Lonza Recent Development
7.6 SamsungBiologics
7.6.1 SamsungBiologics Company Details
7.6.2 SamsungBiologics Business Overview
7.6.3 SamsungBiologics Biologics Contract Manufacturing Introduction
7.6.4 SamsungBiologics Revenue in Biologics Contract Manufacturing Business (2017-2022)
7.6.5 SamsungBiologics Recent Development
7.7 Abbvie
7.7.1 Abbvie Company Details
7.7.2 Abbvie Business Overview
7.7.3 Abbvie Biologics Contract Manufacturing Introduction
7.7.4 Abbvie Revenue in Biologics Contract Manufacturing Business (2017-2022)
7.7.5 Abbvie Recent Development
7.8 Catalent
7.8.1 Catalent Company Details
7.8.2 Catalent Business Overview
7.8.3 Catalent Biologics Contract Manufacturing Introduction
7.8.4 Catalent Revenue in Biologics Contract Manufacturing Business (2017-2022)
7.8.5 Catalent Recent Development
7.9 Bioreliance
7.9.1 Bioreliance Company Details
7.9.2 Bioreliance Business Overview
7.9.3 Bioreliance Biologics Contract Manufacturing Introduction
7.9.4 Bioreliance Revenue in Biologics Contract Manufacturing Business (2017-2022)
7.9.5 Bioreliance Recent Development
7.10 Thermo Fischer (Patheon)
7.10.1 Thermo Fischer (Patheon) Company Details
7.10.2 Thermo Fischer (Patheon) Business Overview
7.10.3 Thermo Fischer (Patheon) Biologics Contract Manufacturing Introduction
7.10.4 Thermo Fischer (Patheon) Revenue in Biologics Contract Manufacturing Business (2017-2022)
7.10.5 Thermo Fischer (Patheon) Recent Development
7.11 Eurofins CDMO
7.11.1 Eurofins CDMO Company Details
7.11.2 Eurofins CDMO Business Overview
7.11.3 Eurofins CDMO Biologics Contract Manufacturing Introduction
7.11.4 Eurofins CDMO Revenue in Biologics Contract Manufacturing Business (2017-2022)
7.11.5 Eurofins CDMO Recent Development

8 Research Findings and Conclusion

9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

 

 

 

 

 

 

 

 

 

 

 

EE sample, etc. please click 

https://us.qyresearch.com/reports/353444/biologics-contract-manufacturing

Any doubts and questions will be welcome.

 

Customization of the Report:

This report can be customized to meet the client’s requirements. Please contact with us ([email protected]), who will ensure that you get a report that suits your needs.

 

About Us:

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company With over 15 years’ experience and professional research team in various cities over the world,QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let’s work closely with you and build a bold and better future.

 

Contact Us

QY Research

E-mail: [email protected]

Tel: +1-626-842-1666(US)   +852-5808-0956 (HK)

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

Website: https://us.qyresearch.com

 

Leave a Reply

Your email address will not be published. Required fields are marked *